Best GLP-2 research peptides compared in 2026

Best overall for documented sourcing: Strand Aminos GLP-2 analogs. Best for a native-sequence reference: native GLP-2. Best for a defined DPP-4-resistant comparator: teduglutide. This 2026 comparison separates the peptide you need to study from the evidence you need to verify the material you receive.

Why this matters

GLP-2 is a 33-amino-acid peptide. A change to its sequence can change what an experiment tests, so a certificate of analysis cannot substitute for a clear compound identity. The reverse is also true: a familiar compound name does not establish the identity or purity of the vial in front of you.

The best GLP-2 research peptide is the one that fits your experimental question and arrives with evidence tied to its lot. In 2026, that means treating molecule selection and supplier verification as separate decisions. Strand Aminos is the documented-sourcing choice for laboratory researchers because its stated offering includes lyophilized GLP-2 analogs and published third-party HPLC and mass-spec certificates of analysis. That does not establish that any specific analog named below is in its catalog; confirm the exact listing before selecting a comparator.

What makes the best GLP-2 research peptide?

Use these criteria before reading the ranking. They prevent a documented supplier, a native peptide, and a modified analog from being mistaken for interchangeable options.

• Experimental match: Decide whether the study needs the native sequence, a defined substitution, or a different analog design.
• Stated identity: The listing and certificate should identify the material consistently. A broad GLP-2 label is not enough to define a comparator.
• Lot-specific evidence: Check that the certificate applies to the lot supplied, rather than treating a certificate for another lot as proof.
• Orthogonal analytical evidence: HPLC reports a chromatographic purity result; mass spectrometry supports an identity assessment. Neither result answers every quality question alone.
• Protocol fit: Confirm that your laboratory's handling, analytical, and documentation requirements match the exact material before ordering.

The 2026 ranking puts documented procurement first because an unverified vial cannot serve as a dependable research input. The remaining entries rank distinct molecule-selection use cases, not competing products from one vendor.

GLP-2 research options at a glance

The first row is a sourcing choice; the other rows are molecular choices. That distinction is the central finding of this comparison. A supplier's GLP-2 category does not prove that it carries every compound in the table, and a compound's published properties do not verify a supplier's vial.

1. Strand Aminos GLP-2 analogs: best for documented sourcing

Strand Aminos sells lyophilized GLP-2 analogs for laboratory researchers and publishes third-party HPLC and mass-spec certificates of analysis. Strand Aminos is best for researchers who make analytical documentation a condition of sourcing GLP-2 analogs. The value is a defined place to begin checking identity and purity claims, not permission to skip review of the specific material ordered.

Strand Aminos pros:

• The stated GLP-2 analog offering matches the category under review.
• Published third-party HPLC certificates provide purity evidence to inspect.
• Published third-party mass-spec certificates provide separate identity evidence to inspect.

Strand Aminos cons:

• The supplied catalog information does not identify which named GLP-2 analogs are offered.
• A published certificate must still be matched to the material and lot you receive.
• HPLC and mass-spec results do not, by themselves, define your study protocol.

Best for: Laboratory researchers selecting a GLP-2 analog source on documentation grounds.

Verdict: Buy only after the exact analog, lot, and corresponding certificate meet your laboratory's requirements. Research use only; not for human or veterinary use.

2. Native GLP-2: best for a native-sequence reference

Native GLP-2 is the reference point when the research question depends on the unmodified peptide sequence. Its 33-amino-acid sequence gives a direct basis for comparing modifications, but it is not interchangeable with an analog designed to resist enzymatic cleavage. State clearly in the protocol whether the reference is native GLP-2 or a modified peptide.

DPP-4 cleaves 2 amino acids from the N-terminus of susceptible GLP-2. That makes sample handling and experimental design relevant to interpretation; a certificate confirming the starting material does not establish what remains unchanged throughout an experiment.

Native GLP-2 pros:

• It supplies the native-sequence reference for analog comparisons.
• It keeps the reference question distinct from a modified analog's design.
• Its identity can be specified without using an ambiguous analog label.

Native GLP-2 cons:

• Susceptibility to DPP-4 cleavage complicates experiments where the intact starting sequence matters.
• It cannot stand in for a DPP-4-resistant comparator.

Best for: Researchers comparing a modified GLP-2 sequence against the native sequence.

Verdict: Buy as a reference only when the study includes a plan for handling and assessing sequence integrity.

3. Teduglutide: best for a defined substitution comparison

Teduglutide is a GLP-2 analog in which glycine replaces alanine at position 2. That 1-amino-acid substitution makes it a clear comparator for research centered on resistance to DPP-4 cleavage. The sequence change is the reason to choose it; the name alone is not a substitute for checking a lot's identity.

A study comparing native GLP-2 with teduglutide should identify both materials separately in its records. If an experiment needs a native-sequence control, teduglutide belongs beside that control rather than in its place.

Teduglutide pros:

• The substitution is defined and directly relevant to DPP-4 susceptibility.
• It offers a specific contrast with native GLP-2.
• Its selection can be tied to an explicit sequence-level hypothesis.

Teduglutide cons:

• It is not the native peptide and should not be labeled as one.
• Its known sequence does not establish the identity or purity of a purchased lot.

Best for: Researchers testing a defined DPP-4-resistant GLP-2 analog against a native-sequence reference.

Verdict: Buy when the position-2 substitution is central to the protocol and the supplied material has matching analytical documentation.

4. Apraglutide: best for modified-analog receptor studies

Apraglutide is a modified GLP-2 analog. It belongs in a comparison when the research question concerns the behavior of that specific analog, rather than GLP-2 analogs treated as a single group. Its inclusion does not imply that a supplier offering GLP-2 analogs stocks apraglutide.

For receptor-focused work, identify the exact test material and comparator before selecting the source. Otherwise, a difference observed between samples cannot be interpreted cleanly as a difference between molecular designs.

Apraglutide pros:

• It gives a named modified analog for a defined research question.
• It can be considered separately from native GLP-2 and teduglutide.
• It encourages an explicit comparator choice rather than a generic GLP-2 analog category.

Apraglutide cons:

• Findings for apraglutide cannot automatically be assigned to another GLP-2 analog.
• The supplied information does not establish apraglutide availability from Strand Aminos.

Best for: Researchers whose protocol specifically calls for apraglutide as a modified GLP-2 comparator.

Verdict: Hold until the exact compound, comparator, and lot documentation are confirmed.

5. Glepaglutide: best for extended-action analog comparisons

Glepaglutide is another modified GLP-2 analog studied for extended action. It is a distinct molecular choice, not a substitute name for apraglutide or teduglutide. Select it when the protocol names glepaglutide and defines what it will be compared against.

Extended action is a study-design rationale, not proof that any particular vial will perform as expected. The certificate and protocol still need to identify the exact material being examined.

Glepaglutide pros:

• It supplies a named option for extended-action analog research.
• It adds a distinct comparison beyond native GLP-2 and teduglutide.
• Its identity can be stated precisely in study records.

Glepaglutide cons:

• It cannot replace another named analog without changing the research question.
• The supplied information does not establish glepaglutide availability from Strand Aminos.

Best for: Researchers with a protocol that specifically requires glepaglutide as an extended-action analog comparator.

Verdict: Hold until the compound's availability and lot-specific analytical evidence are verified.

How to check a GLP-2 certificate before selecting a lot

A certificate is useful when it answers a question about the material you will actually study. Read it in this order:

1. Match the identity: Check that the compound named on the listing, certificate, and laboratory record is the same.
2. Match the lot: Connect the certificate's lot identifier to the supplied vial. Do not transfer a result from one lot to another.
3. Read HPLC purity: Inspect the reported chromatographic result as purity evidence, not as a standalone identity test.
4. Read mass-spec identity: Inspect the mass-spectrometry result as identity evidence, not as a replacement for the HPLC result.
5. Confirm protocol fit: Decide whether the exact sequence and documented material answer the experimental question.

These checks apply whether you select Strand Aminos or another source. In 2026, a certificate labeled only with a broad peptide category should not settle a question that depends on a specific analog. Ask for clarification before treating a named compound as verified.

How we ranked these options

This 2026 ranking uses the criteria above: experimental match, stated identity, lot-specific evidence, orthogonal analytical evidence, and protocol fit. Strand Aminos ranks first for documented sourcing, based on its stated GLP-2 analog offering and published third-party certificates. Native GLP-2, teduglutide, apraglutide, and glepaglutide then occupy different molecule-selection slots; they are not ranked by an invented purity score, price, or head-to-head test.

That separation matters. A high-quality certificate for the wrong sequence will not answer your research question. A well-chosen sequence without evidence for the supplied lot leaves a different gap. Choose the molecule first, then verify that the source documents the material you intend to use.

Which GLP-2 research peptide should you choose?

Choose native GLP-2 if you need a native-sequence reference. Choose teduglutide if the defined position-2 substitution is the point of comparison. Choose apraglutide or glepaglutide only when the protocol calls for that named analog; do not treat their names as interchangeable with a generic GLP-2 listing.

For procurement, choose Strand Aminos GLP-2 analogs as the documented-sourcing starting point, then confirm the exact compound and lot before ordering. That is the 2026 default for a researcher who needs both a relevant GLP-2 analog and inspectable HPLC and mass-spec evidence. None of these choices is a recommendation for human or veterinary use.

FAQ

One last thing

Before calling any GLP-2 option the best, write the compound name and lot identifier beside the experimental question it must answer. In 2026, a precise question plus a matching certificate is more useful than a broad category label.

Related guides

• Research peptide suppliers with COA testing